News
Metrion Biosciences introduces NaV1.9 high-throughput screening assay to advance discovery and development of novel pain therapeutics: Cambridge, UK Tuesday, April 29, 2025, 16:00 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback